Alzheimer’s Drug Market To Top $10B By 2021
The market is expected to by a compound annual growth rate of 11%.
All articles by Jonathan Block
Impact of Past Experiences on Memories Could Influence Alzheimer’s
Researchers set out to examine the idea that past experience with an object alters the brain circuitry responsible for object recognition.
Stress Hormone Lowering Drug Doesn’t Benefit Depression
New research questions the efficacy of metyrapone as an adjunctive treatment for treatment-resistant depression.
Obama Pledges Additional $1.1B To Combat Opioid Abuse
The $1.1 billion figure is on top of the $400 million already included in the December budget agreement.
Brain Cell Deficit May Contribute to Schizophrenia
In a mouse model of schizophrenia, the rodents’ brains showed a significant decrease in inhibitory CA2 neurons.
Long-Term Use of Opioids Boosts Depression Risk
New onset of depression is associated with longer duration of opioid use.
Meditation for PTSD Soldiers Can Reduce Need for Meds
After one month of transcendental meditation, more than 80% of active-duty soldiers with PTSD had stabilized, reduced, or stopped taking meds.
WHO Opposes Chinese Request to Restrict Access to Ketamine
China’s U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.
New Drug Target Found for Autism
Nerve cells from Rett Syndrome patients saw increased levels of an important molecule critical for neurotransmitter functioning after being given IGF1.
Mental Health Improvements Part of Obama’s Gun Control Action
Obama has proposed a $500 million investment to improve access to mental health care as part of gun control reform.
